Indap

Indapamide, the active ingredient in Indap, is a thiazide-like diuretic presented as a tablet for oral use. It treats hypertension and reduces fluid overload in patients with congestive heart failure. GNH USA supplies Indap as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide is a thiazide‑like diuretic that acts on fluid balance and vascular resistance. Hypertension: lowers systemic blood pressure and reduces cardiovascular risk. Edema associated with congestive heart failure: promotes fluid excretion to relieve swelling. High blood pressure in chronic kidney disease: helps control hypertension while preserving renal function.

Indapamide may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Increased urination - Dizziness or light‑headedness - Electrolyte imbalance (especially low potassium) - Headache - Muscle cramps - Fatigue

Serious or Rare Side Effects: - Severe dehydration - Acute kidney injury - Hyponatremia - Hyperuricemia leading to gout attacks - Allergic reactions such as rash or angioedema - Blood dyscrasias (e.g., leukopenia)

When prescribing Indapamide, clinicians should consider several safety measures to minimize risk. Assess renal function: evaluate baseline creatinine and eGFR before initiation. Monitor electrolytes: check serum potassium and sodium periodically. Avoid in severe hepatic impairment: use with caution or not at all. Consider drug interactions: review concomitant medications that affect potassium or renal function. Pregnancy and lactation: use only if benefits outweigh risks, as safety data are limited. Store at ambient temperature: keep below 25°C, retain in original container, protect from moisture.

Indapamide can influence the pharmacokinetics or pharmacodynamics of several co‑administered agents.

Major Interactions (Avoid): - Lithium: may increase lithium levels and toxicity. - NSAIDs: can reduce diuretic efficacy and impair renal function. - ACE inhibitors or ARBs: heightened risk of potassium loss and renal impairment. - Other thiazide diuretics: additive electrolyte disturbances. - High‑dose potassium supplements: risk of hyperkalemia.

Moderate Interactions (Monitor Closely): - Antidiabetic drugs: diuretic may affect glucose control. - Other antihypertensives: additive blood pressure lowering. - Corticosteroids: may increase sodium loss. - Digoxin: altered serum levels due to electrolyte changes. - Warfarin: possible alteration in INR.